Sponsor Pipeline

Li-kun Chen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06728852 Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for… Advanced Non-small Cell Lung Cancer (NSCLC) Recruiting
NCT06728865 Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As… Non-small Cell Lung Cancer (NSCLC) Recruiting
NCT07197008 Sacituzumab Tirumotecan (Sac-TMT) Plus Bevacizumab in 3rd Generation EGFR-TKI Treated… Lung Cancer Not Yet Recruiting
Disease Areas
Lung Cancer (3) Non-Small Cell Lung Cancer (NSCLC) (2)
Get alerts when Li-kun Chen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free